D89.44 Code facturable et spécifique Hereditary alpha tryptasemia

ICD-10-CM D89.44 identifies “Hereditary alpha tryptasemia” as a billable/specific code in the FY2027 U.S. classification, effective October 1, 2026 through September 30, 2027.

Chapitre 3: Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

Instructions du code

Use additional code3
  • code, if applicable, for:
  • allergy status, other than to drugs and biological substances (Z91.0-)
  • personal history of anaphylaxis (Z87.892)

Instructions des niveaux supérieurs

Chapitres 3 · Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism (D50-D89)

Excludes 29
  • autoimmune disease (systemic) NOS (M35.9)
  • certain conditions originating in the perinatal period (P00-P96)
  • complications of pregnancy, childbirth and the puerperium (O00-O9A)
  • congenital malformations, deformations and chromosomal abnormalities (Q00-Q99)
  • endocrine, nutritional and metabolic diseases (E00-E88)
  • human immunodeficiency virus [HIV] disease (B20)
  • injury, poisoning and certain other consequences of external causes (S00-T88)
  • neoplasms (C00-D49)
  • symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified (R00-R94)

D80-D89 · Certain disorders involving the immune mechanism (D80-D89)

Includes3
  • defects in the complement system
  • immunodeficiency disorders, except human immunodeficiency virus [HIV] disease
  • sarcoidosis
Excludes 12
  • autoimmune disease (systemic) NOS (M35.9)
  • functional disorders of polymorphonuclear neutrophils (D71-)
Excludes 21

human immunodeficiency virus [HIV] disease (B20)

D89 · Other disorders involving the immune mechanism, not elsewhere classified

Excludes 12
  • hyperglobulinemia NOS (R77.1)
  • monoclonal gammopathy (of undetermined significance) (D47.2)
Excludes 21

transplant failure and rejection (T86.-)

D89.4 · Mast cell activation syndrome and related disorders

Excludes 111
  • aggressive systemic mastocytosis (C96.21)
  • congenital cutaneous mastocytosis (Q82.2)
  • (non-congenital) cutaneous mastocytosis (D47.01)
  • (indolent) systemic mastocytosis (D47.02)
  • malignant mast cell neoplasm (C96.2-)
  • malignant mastocytoma (C96.29)
  • mast cell leukemia (C94.3-)
  • mast cell sarcoma (C96.22)
  • mastocytoma NOS (D47.09)
  • other mast cell neoplasms of uncertain behavior (D47.09)
  • systemic mastocytosis associated with a clonal hematologic non-mast cell lineage disease (SM-AHNMD) (D47.02)
Références de l’index officiel

Références de l’index officiel (3)

Hereditary alpha tryptasemia(syndrome) (1)
Syndrome (1)
Tryptasemia, hereditary alpha (1)

Historique officiel de conversion

Historical assignments from the CDC conversion table support data retrieval. They do not authorize substituting a previous code for the current code.

Dates de validité 2021-10-01

Attribution précédente: D89.49

Historique

Historique du code

Dernière modification enregistrée · FY2027

ModifiéInchangé
FY2027Édition sélectionnée

En vigueur dès le

  • Instructions héritées modifiées

Hereditary alpha tryptasemia

Code de diagnostic facturable

CDC/NCHS · FY2027

Toutes les éditions (11)

Toutes les éditionsEn vigueur dès leHistorique du code
FY20222021-10-01Ajouté
FY2022 · 04-012022-04-01Aucun changement tabulaire
FY20232022-10-01Aucun changement tabulaire
FY2023 · 04-012023-04-01Aucun changement tabulaire
FY20242023-10-01Aucun changement tabulaire
FY2024 · 04-012024-04-01Aucun changement tabulaire
FY20252024-10-01Aucun changement tabulaire
FY2025 · 04-012025-04-01Aucun changement tabulaire
FY20262025-10-01Instructions héritées modifiées
FY2026 · April2026-04-01Aucun changement tabulaire
FY20272026-10-01Instructions héritées modifiées

Cette entrée est un code complet dans l’édition sélectionnée. La vérification du référentiel ne confirme pas la pertinence clinique et ne garantit pas le remboursement.